Muņoz, Ana M <br/><br/>
Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.  [electronic resource] 

 -  Journal of neuroscience research  May 2004 
 - 551-62 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-4012 
<br/><br/><label>Standard No.: </label>10.1002/jnr.20107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--administration & dosage<br/>Animals<br/>Antigens, CD<br/>Antigens, Neoplasm<br/>Antigens, Surface<br/>Ascorbic Acid<br/>Avian Proteins<br/>Basigin<br/>Blood Proteins<br/>Cell Count<br/>Corpus Striatum--cytology<br/>Cysteine--administration & dosage<br/>Dopamine--metabolism<br/>Drug Administration Routes<br/>Female<br/>Fluoresceins<br/>Fluorescent Dyes--metabolism<br/>Free Radical Scavengers--administration & dosage<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Heme Oxygenase (Decyclizing)--metabolism<br/>Heme Oxygenase-1<br/>Hydroxydopamines<br/>Immunohistochemistry--methods<br/>Membrane Glycoproteins--metabolism<br/>Nerve Degeneration--chemically induced<br/>Neurons--drug effects<br/>Organic Chemicals<br/>Phosphopyruvate Hydratase--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tyrosine 3-Monooxygenase--metabolism